Study Details

A Trial of the FMS-like tyrosine kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients with FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)

This trial is complete
The study has ended normally, and participants are no longer being examined or treated (that is, the last participant's last visit has occurred). ID

The unique identification code given to each clinical study upon registration at

Astellas Study ID

The unique identification code given by the study sponsor.


EudraCT ID

The unique identification code given to each clinical study upon registration at EudraCT (European Union Drug Regulating Authorities Clinical Trials Database).



Leukemia - AML


These clinical trials are done to confirm that an experimental treatment helps participants who have a specific condition. These clinical trials often compare the experimental treatment to another treatment or, if appropriate, a placebo.

Phase 3


18 years - N/A


Female & Male




A type of clinical study in which participants are assigned to groups that receive one or more intervention/treatment (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.


Trial Dates

Jun 2017 - May 2023


Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Enrollment number


A Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Trial of the FLT3 Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients with FLT3/ITD AML

Study summary

Get More Information

Would you like more information about clinical trial sites that are recruiting participants for A Trial of the FMS-like tyrosine kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients with FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)? Contact us by filling our your information to the right and we’ll respond to you.

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.


Site ES34002

Valencia, Spain

University of California, San Diego

La Jolla, United States, 92093

Karmanos Cancer Center

Detroit, United States, 48201

Oregon Health and Science University

Portland, United States, 97239

Site PL48001

Wroclaw, Poland

Site KR82003

Seoul, Republic of Korea

Site JP81001

Fukuoka, Japan

Site GB44009

Glasgow, United Kingdom, G12 0YN

Site BE32001

Liege, Belgium

Site JP81020

Shinjuku-ku, Japan

Site JP81008

Shimotsuke, Japan

Site AU61001

Liverpool, Australia

Site TW88605

Taoyuan, Taiwan, Province of China

Site PL48004

Warszawa, Poland

Site DK45001

Copenhagen, Denmark

Site JP81014

Anjo, Japan

Beth Israel Deaconess Medical Center

Boston, United States, 02215

Site TW88602

Taipei, Taiwan, Province of China

Texas Transplant Institute

San Antonio, United States, 78229

Site GB44004

London, United Kingdom

Site GR30003

Rio, Greece

Site JP81017

Okayama, Japan

Site FR33007

Lille, France

Site FR33002

Toulouse Cedex 9, France

Site DE49009

Stuttgart, Germany

Roswell Park Cancer Institute

Buffalo, United States, 14263

Site FR33010

Vandoeuvre-Les-Nancy, France

Site KR82001

Seoul, Republic of Korea

Massachusetts General Hospital

Boston, United States, 02114

Loyola University Medical Center

Maywood, United States, 60153

Site GR30002

Athens, Greece

Rutgers CINJ

New Brunswick, United States, 08903

University Hospitals of Cleveland Medical Center

Cleveland, United States, 44106

Site PL48003

Krakow, Poland

Site GR30001

Thessaloniki, Greece

Medical College of Wisconsin

Milwaukee, United States, 53226

Site IT39011

Pescara, Italy

Site FR33006

Montpellier Cedex 5, France

Site IT39007

Milano, Italy

Site GB44003

Bristol, United Kingdom

Site KR82002

Seoul, Republic of Korea

University of Nebraska Medical Center

Omaha, United States, 68198

Virginia G Piper Cancer Center

Scottsdale, United States, 85258

Site DE49007

Mainz, Germany

Site ES34005

Barcelona, Spain

Site TW88601

Kaohsiung, Taiwan, Province of China

Johns Hopkins Hospital

Baltimore, United States, 21231

Yale University School of Medicine

New Haven, United States, 06511

University of Virginia

Charlottesville, United States, 22908

Site ES34007

Santander, Spain

Site IT39004

Udine, Italy

University of Pennsylvania

Philadelphia, United States, 19104

Site FR33008

Pessac, France

Site BE32002

Edegem, Belgium

University of North Carolina

Chapel Hill, United States, 27599

Site JP81021

Kobe, Japan

University of Florida

Gainesville, United States, 32610

Site DE49002

Düsseldorf, Germany

Site DE49005

Hamburg, Germany

Site JP81011

Nagoya, Japan

Site FR33009

Marseille, France

Site ES34004

Barcelona, Spain, 08036

Site DE49003

Halle (Saale), Germany

Site JP81016

Minato-ku, Japan

Tufts Medical Center

Boston, United States, 02111

Oncology Hematology Care, Inc

Cincinnati, United States, 45242

Ohio State University, The

Columbus, United States, 43210

Site JP81002

Isehara, Japan

Site JP81018

Sapporo, Japan

Site AU61002

Melbourne, Australia

Site JP81013

Bunkyo-ku, Japan

Huntsman Cancer Institute

Salt Lake City, United States, 84143

Augusta University

Augusta, United States, 30912

Site DE49004

Münster, Germany

University of Wisconsin Hospital and Clinics

Madison, United States, 53792

Site CA15003

Montreal, Canada

Site GB44002

Manchester, United Kingdom

Mayo Clinic

Rochester, United States, 55905

Indiana Blood and Marrow Transplant

Indianapolis, United States, 46237

Site JP81015

Kyoto, Japan

Site IT39002

Milano, Italy

Vanderbilt University Medical Center

Nashville, United States, 37232

Site KR82004

Seoul, Republic of Korea

Stanford University

Stanford, United States, 94305

Fred Hutchinson Cancer Research Center

Seattle, United States, 98109

University of Alabama at Birmingham

Birmingham, United States, 35294

Site IT39009

Genova, Italy, 16132

H. Lee Moffitt Cancer Center

Tampa, United States, 33612

Wake Forest Baptist Health

Winston-Salem, United States, 27157

Cleveland Clinic

Cleveland, United States, 44195

Site JP81004

Chuo-ku, Japan

University of California San Francisco

San Francisco, United States, 94143

Site FR33004

Lyon, France

Washington University in St. Louis

St. Louis, United States, 63110

Site BE32004

Gent, Belgium

Site GB44001

Sutton, United Kingdom


Atlanta, United States, 30342

Baylor College of Medicine

Houston, United States, 77030

Site JP81005

Osaka, Japan

University of Miami

Miami, United States, 33136

Site IT39005

Bergamo, Italy

University of Kansas Medical Center

Kansas City, United States, 66160-7233

Site JP81003

Fukuoka, Japan

University of Maryland Medical Systems

Baltimore, United States, 21201

Site TW88603

Taichung, Taiwan, Province of China

Mayo Clinic

Phoenix, United States, 85054

Site FR33005

Paris, France

Site DK45002

Arhus, Denmark

Emory University

Atlanta, United States, 30322

Site JP81006

Suita, Japan

Site FR33012

Besancon, France

Duke University Medical Center

Durham, United States, 27710

University of Michigan

Ann Arbor, United States, 48109

Site NZ64001

Grafton, New Zealand, 1010

Site CA15002

Winnipeg, Canada

Weill Cornell Medical Center

New York, United States, 10065

Site GB44010

Birmingham, United Kingdom

West Virginia University Hospital

Morgantown, United States, 26506-9214

Dana Farber Cancer Institute

Boston, United States, 02215

Northwestern Memorial Hospital

Chicago, United States, 60611

Site BE32003

Bruxelles, Belgium

Site JP81012

Nishinomiya, Japan

Medical University of South Carolina

Charleston, United States, 29425

Site JP81019

Kagoshima, Japan

Virginia Commonwealth University

Richmond, United States, 23298

Site ES34006

Salamanca, Spain

Site GB44005

Nottingham, United Kingdom

Site JP81007

Yokohama, Japan

Site JP81010

Sendai, Japan

Site AU61004

Westmead, Australia

Site NZ64002

Christchurch, New Zealand

Memorial Sloan Kettering

New York, United States, 10065

Site DE49006

Köln, Germany

Intermountain BMT

Salt Lake City, United States, 84143

Site NZ64003

Dunedin, New Zealand, 9001

Rush University Medical Center

Chicago, United States, 60612

Site GR30004

ATHENS, Greece

Site KR82005

Seoul, Republic of Korea

Site IT39006

Bologna, Italy

Site NZ64004

Wellington, New Zealand

Site FR33003

Paris, France

University of Massachusetts

Worcester, United States, 01655

Site CA15004

Hamilton, Canada

University of Minnesota School of Medicine

Minneapolis, United States, 55455

Site IT39014

Roma, Italy, 161

Penn State Hershey Medical Center

Hershey, United States, 17033

Site ES34003

Barcelona, Spain

Site IT39001

Torino, Italy

Site IT39003

Roma, Italy